Literature DB >> 32165297

Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC.

Dong-Dong Guo1, Kun-Feng Xie1, Xing-Jing Luo2.   

Abstract

Hypoxia, as a form of stress, plays a critical role in oncogenesis, including metabolic reprogramming. Mitochondrial, the centers of energy production, re-balance mitochondria dynamic to maintain cell survival during high levels of environmental stresses. NDRG1 is a hypoxia-inducible protein that is involved in various human cancers, including HCC. However, little is known about whether NDRG1 participants in the quality control of mitochondrial in times of stress. Here, we firstly showed that how NDRG1 exerted its role through mediating mitochondrial dynamic in HCC cells under hypoxia. Initially, we identified that NDRG1 expression varies with oxygen content. NDRG1 silencing notably induced cell apoptosis under hypoxia, while no obviously change of wildtype cells in hypoxia compared with that in normoxia. Further analysis revealed that NDRG1 silencing in HCC cells led to increase of pro apoptotic protein BAX and decrease in anti-apoptotic proteins Bcl-2 and Bclx, which meant mitochondrial damage were induced. In the analysis of mitochondria, we found that more released cytochrome c located in cytosolic with NDRG1 knockdown in hypoxia, which may be due to mitochondria division. And the following experiment proved that more fragmented mitochondria were presented in NDRG1 silencing cells, as well as destroyed mitochondrial membrane potential with evidence by JC-1 was verified. Moreover, these trends could be reversed by Mdivi1. Further research showed that NDRG1 silencing disrupt hypoxia-enhanced aerobic glycolysis through effectively decreased glucose uptake, lactate output and ECAR value. In sum, we provide the first direct evidence that NDRG1-driven change in mitochondrial dynamics and aerobic glycolysis maintain cells survival in HCC during hypoxia.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  NDRG1; glycolysis; hypoxia; mitochondrial dynamics

Year:  2020        PMID: 32165297     DOI: 10.1016/j.gene.2020.144552

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Machine Learning for Building Immune Genetic Model in Hepatocellular Carcinoma Patients.

Authors:  Jun Liu; Zheng Chen; Wenli Li
Journal:  J Oncol       Date:  2021-03-17       Impact factor: 4.375

2.  Silencing LINC00294 Restores Mitochondrial Function and Inhibits Apoptosis of Glioma Cells under Hypoxia via the miR-21-5p/CASKIN1/cAMP Axis.

Authors:  Xiaogang Dong; Qin Pi; Anwaier Yuemaierabola; Wenjia Guo; Hailong Tian
Journal:  Oxid Med Cell Longev       Date:  2021-11-03       Impact factor: 6.543

3.  MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the Optic atrophy 3 promoter and activating its expression.

Authors:  Miao Liu; Qiang Du; Gang Mao; Ning Dai; Fan Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

4.  A Novel Hypoxia Related Marker in Blood Link to Aid Diagnosis and Therapy in Osteoarthritis.

Authors:  Shunhan Yao; Meiling Deng; Xiaojing Du; Rongzhi Huang; Qingfeng Chen
Journal:  Genes (Basel)       Date:  2022-08-23       Impact factor: 4.141

5.  NDRG1 regulates osteosarcoma cells via mediating the mitochondrial function and CSCs differentiation.

Authors:  Tong Zhao; Ying Meng; Yongping Wang; Wenji Wang
Journal:  J Orthop Surg Res       Date:  2021-06-07       Impact factor: 2.359

6.  A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma.

Authors:  Yongfeng Hui; Junzhi Leng; Dong Jin; Di Liu; Genwang Wang; Qi Wang; Yanyang Wang
Journal:  Dis Markers       Date:  2021-10-21       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.